These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 23550992)
1. Arsenic: an old enemy now turned friend. Firkin F; Iland H Leuk Lymphoma; 2013 Sep; 54(9):1864-6. PubMed ID: 23550992 [No Abstract] [Full Text] [Related]
2. Determination of arsenic metabolites in patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide. Zhang Z; Chen Y; Meng H; Sui M; Zhou Q; Shi C; Han L; Wang H; Zhou J Leuk Lymphoma; 2013 Sep; 54(9):2041-6. PubMed ID: 23343178 [TBL] [Abstract][Full Text] [Related]
3. The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia. Zhu H; Hu J; Chen L; Zhou W; Li X; Wang L; Zhao X; Zhang Y; Zhao H; Wang A; Chen Y; Sun H; Chen Q; Chen Y; Zhao W; Mi J; Shen Z; Wang Z; Chen Z; Chen S; Li J Blood; 2016 Sep; 128(11):1525-8. PubMed ID: 27402972 [No Abstract] [Full Text] [Related]
4. Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Chen B; Cao F; Yuan C; Lu X; Shen S; Zhou J; Le XC Anal Bioanal Chem; 2013 Feb; 405(6):1903-11. PubMed ID: 23318765 [TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetic study of arsenic trioxide in an acute promyelocytic leukemia (APL) patient: speciation of arsenic metabolites in serum and urine. Fukai Y; Hirata M; Ueno M; Ichikawa N; Kobayashi H; Saitoh H; Sakurai T; Kinoshita K; Kaise T; Ohta S Biol Pharm Bull; 2006 May; 29(5):1022-7. PubMed ID: 16651738 [TBL] [Abstract][Full Text] [Related]
6. [Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia]. Lengfelder E; Schultheis B; Büchner T; Hehlmann R Dtsch Med Wochenschr; 2007 Feb; 132(7):330-6. PubMed ID: 17286223 [No Abstract] [Full Text] [Related]
7. Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement. Knipp S; Gattermann N; Schapira M; Käferstein H; Germing U Leuk Res; 2007 Nov; 31(11):1585-7. PubMed ID: 17416415 [TBL] [Abstract][Full Text] [Related]
8. Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia. Torka P; Al Ustwani O; Wetzler M; Wang ES; Griffiths EA Blood Rev; 2016 May; 30(3):201-11. PubMed ID: 26709030 [TBL] [Abstract][Full Text] [Related]
9. Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical and basic studies. Zhao WL; Chen SJ; Shen Y; Xu L; Cai X; Chen GQ; Shen ZX; Chen Z; Wang ZY Leuk Lymphoma; 2001; 42(6):1265-73. PubMed ID: 11911407 [TBL] [Abstract][Full Text] [Related]
10. Speciation of arsenic trioxide metabolites in blood cells and plasma of a patient with acute promyelocytic leukemia. Yoshino Y; Yuan B; Miyashita SI; Iriyama N; Horikoshi A; Shikino O; Toyoda H; Kaise T Anal Bioanal Chem; 2009 Jan; 393(2):689-97. PubMed ID: 19009285 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide. Fujisawa S; Ohno R; Shigeno K; Sahara N; Nakamura S; Naito K; Kobayashi M; Shinjo K; Takeshita A; Suzuki Y; Hashimoto H; Kinoshita K; Shimoya M; Kaise T; Ohnishi K Cancer Chemother Pharmacol; 2007 Mar; 59(4):485-93. PubMed ID: 16937107 [TBL] [Abstract][Full Text] [Related]
12. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia. Zhang P J Biol Regul Homeost Agents; 1999; 13(4):195-200. PubMed ID: 10703942 [TBL] [Abstract][Full Text] [Related]
13. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Wang Z; Zhou J; Lu X; Gong Z; Le XC Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923 [TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first-line treatment of adult acute promyelocytic leukemia. Cui W; Wang J; Nie RM; Zhao LL; Gao MQ; Zhu HM; Chen L; Hu J; Li JM; Shen ZX; Wang ZY; Chen SJ; Chen Z; Wang KK; Xi XD; Mi JQ Eur J Haematol; 2018 Apr; 100(4):344-350. PubMed ID: 29266395 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide-responsive leukemia cutis in a patient with acute promyelocytic leukemia after ATRA treatment. Wang HX; Duan LN; Ji SQ; Guo ZK Leuk Lymphoma; 2006 Jul; 47(7):1438-40. PubMed ID: 16923589 [No Abstract] [Full Text] [Related] [Next] [New Search]